Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Theravance Bio Ord (NQ: TBPH )

9.600 -0.250 (-2.54%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 381,711
Open 9.710
Bid (Size) 9.200 (1)
Ask (Size) 10.88 (1)
Prev. Close 9.850
Today's Range 9.370 - 9.745
52wk Range 8.210 - 11.71
Shares Outstanding 48,633,224
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
TBPH Stock Earnings: Theravance Biopharma Beats EPS, Beats Revenue for Q1 2024
TBPH stock results show that Theravance Biopharma beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
BTIG Research Predicts Over 118% Rally for These 3 Stocks
Wall Street stock predictions can run wild but after the tech sector's gains, these stocks could be better places for your money. 
Via InvestorPlace

Performance

YTD
-17.17%
-17.17%
1 Month
-0.93%
-0.93%
3 Month
+10.73%
+10.73%
6 Month
-6.71%
-6.71%
1 Year
-7.69%
-7.69%

More News

Read More
Short-Squeeze Showdown: 3 Stocks Ready to Crush the Skeptics
Via InvestorPlace
Recap: Theravance Biopharma Q4 Earnings
Via Benzinga
Logitech Posts Q3 Results, Joins Coinbase And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
Theravance Biopharma Earnings Preview
Via Benzinga
Earnings Scheduled For February 26, 2024
Via Benzinga
A Preview Of Theravance Biopharma's Earnings
Via Benzinga
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Why Is Lung Disease Focused Theravance Biopharma Stock Trading Lower Today?
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Franklin Covey Shares Fall After Q1 Results, Joins Theravance Biopharma, Voyager Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
7 Short-Squeeze Stocks That Are Screaming for Speculation
Via InvestorPlace
Week In Review: Legend Partners DLL3 CAR-T Candidate With Novartis In $1.2 Billion Deal
Via Talk Markets
Roblox, Under Armour, GoPro, Nuvei And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Topics Stocks
Exposures US Equities
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Earnings Scheduled For November 7, 2023
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Takeda Moves Out From Licensing Agreement With Theravance Biopharma
Via Benzinga
Earnings Scheduled For May 8, 2023
Via Benzinga
Tiziana Life Sciences Has Only Fully Human Anti-CD3 mAB In Clinical Studies, Could Be Poised To Improve Care For Patients With Severe Multiple Sclerosis
Via Benzinga
Theravance Biopharma Finally Shelves Failed JAK Inhibitor Program, Lays Off Staff
Via Benzinga
Irenic Sends Letter to Theravance Biopharma Regarding the Urgent Need for a Governance Overhaul, Capital Return and Strategic Review
From Irenic Capital Management, LP
Via Business Wire
Earnings Scheduled For February 27, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.